Asep Medical Holdings Inc
$0.01+0.00%(+$0.00)
TickerSpark Score
34/100
60
Valuation
20
Profitability
15
Growth
44
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SEPSF research report →
52-Week Range0% of range
Low $0.01
Current $0.01
High $0.39
Companyasepmedical.com
Asep Medical Holdings Inc. , through its subsidiary, ASEP Medical Inc. focuses on developing an early diagnostic tool for Sepsis and peptide therapeutic treatments for multiple applications.
- CEO
- Richard Heinzl
- IPO
- 2022
- Employees
- 6
- HQ
- Vancouver, BC, CA
Price Chart
-97.18% · this period
Valuation
- Market Cap
- $121.25K
- P/E
- -0.98
- P/S
- 68.41
- P/B
- 0.64
- EV/EBITDA
- -0.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -538.03%
- Op Margin
- -36524.42%
- Net Margin
- -38918.30%
- ROE
- -58.60%
- ROIC
- -31.34%
Growth & Income
- Revenue
- $21.14K · 0.00%
- Net Income
- $-8,227,328 · -81.82%
- EPS
- $-0.13 · -61.49%
- Op Income
- $-7,721,263
- FCF YoY
- 24.84%
Performance & Tape
- 52W High
- $0.39
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.14
- Beta
- -1.74
- Avg Volume
- 5.48K
Get TickerSpark's AI analysis on SEPSF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SEPSF Coverage
We haven't published any research on SEPSF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SEPSF Report →